Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
Drugs Under Experimental and Clinical Research|January 1, 1996
Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude miceK Umezawa, T Taniguchi, M Toi, et al.Oncology|November 30, 2000
Endocrine therapies for patients with recurrent breast cancer: predictive factors for responses to first- and second-line endocrine therapiesJ Kurebayashi, H Sonoo, H Inaji, et al.Journal of Clinical Pathology|October 31, 2001
CD34 positive stromal cells in gastric adenocarcinomasH Nakayama, H Enzan, E Miyazaki, et al.Japanese Journal of Cancer Research : Gann|May 11, 2001
Expression of multidrug resistance-related transporters in human breast carcinomaA Kanzaki, M Toi, K Nakayama, et al.Histology and Histopathology|April 7, 2006
Cytokeratin-positive subserosal myofibroblasts in gastroduodenal ulcer; another type of myofibroblastsL Guo, N Kuroda, H Nakayama, et al.Journal of Clinical Pathology|December 4, 2002
High molecular weight caldesmon positive stromal cells in the capsule of thyroid follicular tumours and tumour-like lesionsH Nakayama, H Enzan, E Miyazaki, et al.Thrombosis and Haemostasis|March 15, 2001
Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell linesN Tsuneyoshi, K Fukudome, S Horiguchi, et al.Cancer|March 15, 1996
Quantitative analysis of vascular endothelial growth factor in primary breast cancerM Toi, S Kondo, H Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1986
[Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method]M Toi, Y Hamada, Y Seto, et al.Oncology|January 11, 2001
Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosisG Gasparini, M Toi, E Biganzoli, et al.Pageof 22